Cimetidine NDC 63187-333

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-333Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0333Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63187-333-30	63187033330	30 TABLET, FILM COATED in 1 BOTTLE (63187-333-30)Marketed from Jan 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cimetidine
Generic name (nonproprietary): cimetidine
Active ingredients: Cimetidine — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074151
Marketing start: Feb 2, 2004
Listing expires: Dec 31, 2026
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 63187-333_6996efbc-1bc5-48b5-a3d3-38a3595d5f5bSPL ID 6996efbc-1bc5-48b5-a3d3-38a3595d5f5bSPL set ID 5c2e1f52-4021-4f70-9b2b-63af17094187RxCUI 197507UNII 80061L1WGDUPC 0363187333300
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187033330 followed by a unit qualifier and the quantity

Package 63187-0333-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cimetidine tablets are indicated in: • Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see DOSAGE AND ADMINISTRATION , Duodenal Ulcer ). Concomitant antacids should be given as needed for relief of pain. However, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. • Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. Patients have been maintained on continued treatment with cimetidine 400 mg …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074151

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074151
Product	Strength	Form · route	Labeler	Product NDC
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-0500
Cimetidine	Cimetidine 300 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-8192
Cimetidine	Cimetidine 400 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-8204
Cimetidine	Cimetidine 300 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-1783